Evolus Inc.

EOLS | NASDAQ

Price Alert Chart Builder DCF Calculator

$7.99

+$0.13 (+1.65%)

At close: Sep 21, 2026, 4:00 PM ET

$7.99

$0 (0.00%)

After-hours: Sep 21, 2026, 7:30 PM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

+1.65%

(1D)

Rating

Updated: Sep 2, 2026

33.5

Fundamentals Weak

Market Sentiment Neutral

Moat None

Full Analysis

Key Statistics

Market Data

Market Cap $526.18M

1D Range

7.84 8

52W Range

3.86 9.31

Valuation (TTM)

PE -15.37

PB -17.03

EV/EBITDA -63.12

Valuation (NTM)

Forward PE 31.92

Forward PEG 0.02

Price Target $18.40

Cash Flow

FCF Yield -6.0%

SBC Adj. FCF Yield -11.0%

SBC Impact -82.2%

Margins

Gross Margin 66.3%

Operating Margin -7.3%

FCF Margin -10.1%

Growth (CAGR)

Revenue 3Y | 5Y 23.4% | 32.8%

Dil EPS 3Y | 5Y 24.3% | 19.7%

FCF 3Y | 5Y -17.5% | 29.0%

Returns

ROA -13.8%

ROE 123.1%

ROIC -15.3%

Financial Health

Net Debt

$111.57M

Current Ratio 1.70

Interest Coverage -1.43

Dividends

Div Yield N/A

Payout Ratio N/A

FCF Payout Ratio N/A

All Key Statistics

Loading financial charts...

Profile

Evolus, Inc. is a performance beauty enterprise that furnishes the United States market with medical aesthetic solutions for healthcare professionals and their patients. A key product in its portfolio...

Sector Healthcare

Industry Drug Manufacturers - Specialty & Generic

Employees 353

IPO Date Feb 7, 2018

Website www.evolus.com

Fiscal Year January - December

Full Company Profile

Latest News

No news articles available yet.

Earnings

Next Earnings

Nov 4, 2026

EPS Est

Pro

Rev Est

Pro

Earnings Details ➞

Analyst Summary

# of Analysts

Consensus

Buy

Price Target

$17

Upside

+112.77%

Buy (4)

Hold (1)

Sell (0)

Analyst Details ➞